These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 10231305

  • 1. [Lansoprazole: a review of its role in Helicobacter pylori eradication therapy].
    Gisbert JP.
    Rev Esp Enferm Dig; 1999 Feb; 91(2):133-43. PubMed ID: 10231305
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
    Shimoyama T, Fukuda S, Mikami T, Fukushi M, Munakata A.
    J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
    [Abstract] [Full Text] [Related]

  • 3. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Ushiama H, Echizen H, Nachi S, Ohnishi A.
    Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
    [Abstract] [Full Text] [Related]

  • 4. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K, Okimoto T, Kodama M, Sato R, Miyajima H, Ono M, Inoue K, Watanabe K, Otsu S, Fujioka T.
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [Abstract] [Full Text] [Related]

  • 5. Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?
    Maconi G, Parente F, Russo A, Vago L, Imbesi V, Bianchi Porro G.
    Am J Gastroenterol; 2001 Feb; 96(2):359-66. PubMed ID: 11232676
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of lansoprazole on Helicobacter pylori.
    Lamouliatte H.
    Clin Ther; 1993 Feb; 15 Suppl B():32-6. PubMed ID: 8205593
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU, Granström M, Hoang TT, Phuncarg DC, Nilsson LE, Sörberg M.
    Aliment Pharmacol Ther; 2004 Jun 15; 19(12):1315-21. PubMed ID: 15191514
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers].
    Lamouliatte H, Perie F, Joubert-Collin M.
    Gastroenterol Clin Biol; 2000 May 15; 24(5):495-500. PubMed ID: 10891736
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of a nitroimidazole containing tripletherapy regime in Singapore.
    Ling KL, Luman W, Ho B, Ng HS.
    Singapore Med J; 2001 Jul 15; 42(7):317-21. PubMed ID: 11599627
    [Abstract] [Full Text] [Related]

  • 15. Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication.
    Kawano S, Murakami M, Saita H, Tsuji S.
    J Gastroenterol; 1996 Nov 15; 31 Suppl 9():41-3. PubMed ID: 8959517
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection.
    Uthaisaengsook W.
    J Med Assoc Thai; 2003 Jul 15; 86(7):599-602. PubMed ID: 12948252
    [Abstract] [Full Text] [Related]

  • 20. Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country.
    Ahuja V, Dhar A, Bal C, Sharma MP.
    Aliment Pharmacol Ther; 1998 Jun 15; 12(6):551-5. PubMed ID: 9678815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.